retatrutide safety retatrutide clinical trial Efficacy and of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 A new clinical trial from

Verify peptide quality (COA), dose adequacy, and injection consistency

Initially, GLP-1s were developed to treat type 2 diabetes and were marketed for that purpose under brand names such as Ozempic (semaglutide), Rybelsus (semaglutide), Victoza (liraglutide), and Mounjaro (tirzepatide)

doi: 10.1093/eurheartj/ehae568 53

Virta Health helps people improve blood sugar control with medical support and one-on-one virtual coaching, which can reduce diabetes-related dry mouth and other symptoms

While research shows that certain vitamin deficienciessuch as iron, riboflavin, biotin, and in some cases, vitamin Dcan be associated with hair loss, there is not sufficient evidence to support the idea that supplementation of these nutrients fuels hair growth